Rockwell Medical (RMTI) Stock Price, News & Analysis

Company Overview

Rockwell Medical, Inc. is a healthcare company focused on products used in the treatment of patients with end-stage renal disease who receive hemodialysis. The company develops, manufactures and distributes hemodialysis concentrates, including acid and bicarbonate products used to prepare dialysate, the fluid that helps remove waste and excess fluid from the blood during treatment.

Rockwell Medical’s product portfolio also includes Triferic, an iron-replacement therapy based on ferric pyrophosphate citrate. Triferic is designed to deliver iron to adult hemodialysis patients during treatment and is available in formulations intended for use with different dialysis systems. The company markets its products primarily to dialysis providers and healthcare organizations.

Founded in 1996, Rockwell Medical is headquartered in Wixom, Michigan. Its operations have historically centered on serving the U.S. dialysis market, while the company has also pursued opportunities to expand the availability of its products through international and strategic commercial relationships.

Key Stats

• Today's Range: $8.35 to $8.56
• 50-Day Range: $6.28 to $8.85
• 52-Week Range: $4.89 to $12.90
• Volume: 6,423 shs
• Average Volume: 20,941 shs
• Market Capitalization: $33.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.00
• Consensus Rating: Hold

Rockwell Medical Stock Analysis - MarketRank™

Rockwell Medical scored higher than 53% of companies evaluated by MarketBeat, and ranked 479th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Rockwell Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Rockwell Medical has a consensus price target of $20.00, representing about 138.9% upside from its current price of $8.37.

Amount of Analyst Coverage

Rockwell Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Rockwell Medical are expected to grow in the coming year, from ($0.90) to $0.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Rockwell Medical is -6.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Rockwell Medical is -6.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Rockwell Medical has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.34% of the float of Rockwell Medical has been sold short.

Short Interest Ratio / Days to Cover

Rockwell Medical has a short interest ratio ("days to cover") of 4.59.

Change versus previous month

Short interest in Rockwell Medical has recently decreased by 3.35%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Rockwell Medical does not currently pay a dividend.

Dividend Growth

Rockwell Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.45

News Sentiment

Rockwell Medical has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Rockwell Medical this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rockwell Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.60% of the stock of Rockwell Medical is held by insiders.

Percentage Held by Institutions

23.31% of the stock of Rockwell Medical is held by institutions.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/27/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:RMTI
• CIK: 1041024
• Web: www.rockwellmed.com
• Phone: (800) 449-3353
• Fax: 248-960-9119
• Employees: 157
• Year Founded: 1995

Price Target and Rating

• Average Price Target for Rockwell Medical: $20.00
• High Price Target: $20.00
• Low Price Target: $20.00
• Potential Upside/Downside: +138.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.34)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.31 million
• Net Margins: -7.33%
• Pretax Margin: -7.33%
• Return on Equity: -14.03%
• Return on Assets: -8.90%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 3.25
• Quick Ratio: 3.00

Sales & Book Value

• Annual Sales: $69.26 million
• Price / Sales: 0.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.38 per share
• Price / Book: 0.89

Miscellaneous

• Outstanding Shares: 4,030,000
• Free Float: 3,845,000
• Market Cap: $33.73 million
• Optionable: Optionable
• Beta: 1.64